CATHETER PRECISION INC (VTAK) Stock Overview
NYSEARCA:VTAK - US74933X6094 - Common Stock
VTAK Key Statistics, Chart & Performance
The current stock price of VTAK is 3.02 USD. In the past month the price decreased by -27.39%. In the past year, price decreased by -91.55%.
VTAK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.06 | 230.77B | ||
| ISRG | INTUITIVE SURGICAL INC | 59.15 | 170.69B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.52 | 157.32B | ||
| SYK | STRYKER CORP | 30.68 | 150.71B | ||
| MDT | MEDTRONIC PLC | 16.76 | 118.79B | ||
| BDX | BECTON DICKINSON AND CO | 13.99 | 57.23B | ||
| IDXX | IDEXX LABORATORIES INC | 53.75 | 51.64B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.84 | 48.04B | ||
| RMD | RESMED INC | 30.76 | 43.01B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.14 | 34.34B | ||
| DXCM | DEXCOM INC | 48.39 | 32.26B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.97 | 27.29B |
Related stock screener links
About VTAK
Company Profile
Catheter Precision, Inc. engages in the design, manufacture and sale of medical devices and technologies for cardiac electrophysiology. The company is headquartered in Fort Mill, South Carolina and currently employs 22 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The firm's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. The company is developing technology for the treatment of acute decompensated heart failure.
Company Info
CATHETER PRECISION INC
1670 Highway 160 West, Suite 205
Fort Mill SOUTH CAROLINA US
Employees: 22
Phone: 19736912000
CATHETER PRECISION INC / VTAK FAQ
What is the stock price of CATHETER PRECISION INC today?
The current stock price of VTAK is 3.02 USD. The price increased by 1.34% in the last trading session.
What is the ticker symbol for CATHETER PRECISION INC stock?
The exchange symbol of CATHETER PRECISION INC is VTAK and it is listed on the NYSE Arca exchange.
On which exchange is VTAK stock listed?
VTAK stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for CATHETER PRECISION INC stock?
7 analysts have analysed VTAK and the average price target is 38.76 USD. This implies a price increase of 1183.44% is expected in the next year compared to the current price of 3.02. Check the CATHETER PRECISION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CATHETER PRECISION INC worth?
CATHETER PRECISION INC (VTAK) has a market capitalization of 3.71M USD. This makes VTAK a Nano Cap stock.
How many employees does CATHETER PRECISION INC have?
CATHETER PRECISION INC (VTAK) currently has 22 employees.
What are the support and resistance levels for CATHETER PRECISION INC (VTAK) stock?
CATHETER PRECISION INC (VTAK) has a resistance level at 3.63. Check the full technical report for a detailed analysis of VTAK support and resistance levels.
Is CATHETER PRECISION INC (VTAK) expected to grow?
The Revenue of CATHETER PRECISION INC (VTAK) is expected to grow by 533.33% in the next year. Check the estimates tab for more information on the VTAK EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CATHETER PRECISION INC (VTAK) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VTAK, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VTAK, evaluating the profitability, health, valuation and growth aspects
- CATHETER PRECISION INC (VTAK) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CATHETER PRECISION INC (VTAK) Sales and EPS estimates to see what analysts future expectations are.
- CATHETER PRECISION INC (VTAK) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CATHETER PRECISION INC (VTAK) Insider and Institutional Ownership to learn about the owners and their transactions.
- CATHETER PRECISION INC (VTAK) Stock Chart to make your own analysis
- CATHETER PRECISION INC (VTAK) Latest news and press-releases to stay up to date.
Does CATHETER PRECISION INC (VTAK) stock pay dividends?
VTAK does not pay a dividend.
When does CATHETER PRECISION INC (VTAK) report earnings?
CATHETER PRECISION INC (VTAK) will report earnings on 2025-11-11, after the market close.
What is the Price/Earnings (PE) ratio of CATHETER PRECISION INC (VTAK)?
CATHETER PRECISION INC (VTAK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.08).
VTAK Technical Analysis
VTAK Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VTAK. Both the profitability and financial health of VTAK have multiple concerns.
VTAK Financial Highlights
Over the last trailing twelve months VTAK reported a non-GAAP Earnings per Share(EPS) of -9.08. The EPS decreased by -18.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -93.43% | ||
| ROE | -292.71% | ||
| Debt/Equity | 0.01 |
VTAK Forecast & Estimates
7 analysts have analysed VTAK and the average price target is 38.76 USD. This implies a price increase of 1183.44% is expected in the next year compared to the current price of 3.02.
For the next year, analysts expect an EPS growth of 96.27% and a revenue growth 533.33% for VTAK